nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—HTR2A—Gilles de la Tourette syndrome	0.847	1	CbGaD
Trazodone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00418	0.127	CbGeAlD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00158	0.0151	CbGpPWpGaD
Trazodone—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00158	0.015	CbGpPWpGaD
Trazodone—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00151	0.0144	CbGpPWpGaD
Trazodone—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0014	0.0134	CbGpPWpGaD
Trazodone—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00137	0.0131	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00137	0.013	CbGpPWpGaD
Trazodone—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00136	0.013	CbGpPWpGaD
Trazodone—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00136	0.0129	CbGpPWpGaD
Trazodone—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00135	0.0128	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00134	0.0128	CbGpPWpGaD
Trazodone—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00132	0.0125	CbGpPWpGaD
Trazodone—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00131	0.0125	CbGpPWpGaD
Trazodone—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00128	0.039	CbGeAlD
Trazodone—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00127	0.0121	CbGpPWpGaD
Trazodone—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00127	0.0121	CbGpPWpGaD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00125	0.0119	CbGpPWpGaD
Trazodone—Vilazodone—DRD2—Gilles de la Tourette syndrome	0.00124	0.0804	CrCbGaD
Trazodone—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00123	0.0117	CbGpPWpGaD
Trazodone—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00122	0.0116	CbGpPWpGaD
Trazodone—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00122	0.0369	CbGeAlD
Trazodone—ORM1—nervous system—Gilles de la Tourette syndrome	0.00117	0.0356	CbGeAlD
Trazodone—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00117	0.0111	CbGpPWpGaD
Trazodone—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00117	0.0111	CbGpPWpGaD
Trazodone—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00115	0.0109	CbGpPWpGaD
Trazodone—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00114	0.0108	CbGpPWpGaD
Trazodone—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00114	0.0108	CbGpPWpGaD
Trazodone—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00113	0.0108	CbGpPWpGaD
Trazodone—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00113	0.0108	CbGpPWpGaD
Trazodone—ORM1—central nervous system—Gilles de la Tourette syndrome	0.00113	0.0343	CbGeAlD
Trazodone—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00111	0.0106	CbGpPWpGaD
Trazodone—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00111	0.0105	CbGpPWpGaD
Trazodone—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0011	0.0105	CbGpPWpGaD
Trazodone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00108	0.0328	CbGeAlD
Trazodone—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00107	0.0101	CbGpPWpGaD
Trazodone—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00106	0.0101	CbGpPWpGaD
Trazodone—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00106	0.0101	CbGpPWpGaD
Trazodone—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00106	0.0101	CbGpPWpGaD
Trazodone—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00105	0.032	CbGeAlD
Trazodone—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00104	0.00987	CbGpPWpGaD
Trazodone—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00103	0.00985	CbGpPWpGaD
Trazodone—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00103	0.00981	CbGpPWpGaD
Trazodone—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00102	0.00976	CbGpPWpGaD
Trazodone—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00102	0.0308	CbGeAlD
Trazodone—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.001	0.0304	CbGeAlD
Trazodone—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000991	0.0301	CbGeAlD
Trazodone—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000984	0.00937	CbGpPWpGaD
Trazodone—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000982	0.00935	CbGpPWpGaD
Trazodone—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000964	0.00918	CbGpPWpGaD
Trazodone—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000963	0.00917	CbGpPWpGaD
Trazodone—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000963	0.0292	CbGeAlD
Trazodone—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000955	0.0091	CbGpPWpGaD
Trazodone—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000954	0.029	CbGeAlD
Trazodone—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000953	0.00908	CbGpPWpGaD
Trazodone—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000935	0.00891	CbGpPWpGaD
Trazodone—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000895	0.00853	CbGpPWpGaD
Trazodone—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00089	0.00848	CbGpPWpGaD
Trazodone—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00089	0.00847	CbGpPWpGaD
Trazodone—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000888	0.00846	CbGpPWpGaD
Trazodone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000888	0.027	CbGeAlD
Trazodone—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000871	0.0083	CbGpPWpGaD
Trazodone—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000869	0.00828	CbGpPWpGaD
Trazodone—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000858	0.00817	CbGpPWpGaD
Trazodone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000855	0.026	CbGeAlD
Trazodone—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000854	0.00813	CbGpPWpGaD
Trazodone—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000818	0.0248	CbGeAlD
Trazodone—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00081	0.00771	CbGpPWpGaD
Trazodone—HTR2C—brain—Gilles de la Tourette syndrome	0.000806	0.0245	CbGeAlD
Trazodone—Ziprasidone—DRD4—Gilles de la Tourette syndrome	0.000789	0.051	CrCbGaD
Trazodone—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000788	0.0239	CbGeAlD
Trazodone—SLC6A4—brain—Gilles de la Tourette syndrome	0.000764	0.0232	CbGeAlD
Trazodone—HTR2B—brain—Gilles de la Tourette syndrome	0.000757	0.023	CbGeAlD
Trazodone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000757	0.023	CbGeAlD
Trazodone—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00074	0.00705	CbGpPWpGaD
Trazodone—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000726	0.00691	CbGpPWpGaD
Trazodone—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000722	0.00687	CbGpPWpGaD
Trazodone—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000718	0.00684	CbGpPWpGaD
Trazodone—Domperidone—DRD3—Gilles de la Tourette syndrome	0.000688	0.0445	CrCbGaD
Trazodone—Ziprasidone—DRD3—Gilles de la Tourette syndrome	0.00068	0.044	CrCbGaD
Trazodone—HTR1A—brain—Gilles de la Tourette syndrome	0.000679	0.0206	CbGeAlD
Trazodone—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000675	0.00642	CbGpPWpGaD
Trazodone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000644	0.0195	CbGeAlD
Trazodone—HRH1—nervous system—Gilles de la Tourette syndrome	0.000634	0.0192	CbGeAlD
Trazodone—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000629	0.0407	CrCbGaD
Trazodone—ADRA1A—brain—Gilles de la Tourette syndrome	0.000626	0.019	CbGeAlD
Trazodone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000622	0.0189	CbGeAlD
Trazodone—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000622	0.00592	CbGpPWpGaD
Trazodone—Aripiprazole—DRD4—Gilles de la Tourette syndrome	0.000616	0.0399	CrCbGaD
Trazodone—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00061	0.00581	CbGpPWpGaD
Trazodone—HRH1—central nervous system—Gilles de la Tourette syndrome	0.00061	0.0185	CbGeAlD
Trazodone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000599	0.0182	CbGeAlD
Trazodone—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000567	0.0054	CbGpPWpGaD
Trazodone—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000545	0.00519	CbGpPWpGaD
Trazodone—Nefazodone—SLC6A3—Gilles de la Tourette syndrome	0.000532	0.0344	CrCbGaD
Trazodone—Aripiprazole—DRD3—Gilles de la Tourette syndrome	0.000532	0.0344	CrCbGaD
Trazodone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000529	0.0161	CbGeAlD
Trazodone—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00052	0.00495	CbGpPWpGaD
Trazodone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000509	0.0155	CbGeAlD
Trazodone—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000505	0.00481	CbGpPWpGaD
Trazodone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00049	0.0149	CbGeAlD
Trazodone—HRH1—brain—Gilles de la Tourette syndrome	0.000484	0.0147	CbGeAlD
Trazodone—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000482	0.0146	CbGeAlD
Trazodone—Domperidone—DRD2—Gilles de la Tourette syndrome	0.000476	0.0308	CrCbGaD
Trazodone—ADRA2A—brain—Gilles de la Tourette syndrome	0.000476	0.0144	CbGeAlD
Trazodone—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000474	0.0307	CrCbGaD
Trazodone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000472	0.0143	CbGeAlD
Trazodone—Ziprasidone—DRD2—Gilles de la Tourette syndrome	0.000471	0.0305	CrCbGaD
Trazodone—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000464	0.0141	CbGeAlD
Trazodone—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000458	0.00436	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000445	0.00424	CbGpPWpGaD
Trazodone—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000428	0.0277	CrCbGaD
Trazodone—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000422	0.0128	CbGeAlD
Trazodone—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000415	0.00395	CbGpPWpGaD
Trazodone—HTR2A—brain—Gilles de la Tourette syndrome	0.000404	0.0123	CbGeAlD
Trazodone—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000398	0.0257	CrCbGaD
Trazodone—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000395	0.0255	CrCbGaD
Trazodone—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.000385	0.0249	CrCbGaD
Trazodone—CYP2D6—brain—Gilles de la Tourette syndrome	0.000368	0.0112	CbGeAlD
Trazodone—Aripiprazole—DRD2—Gilles de la Tourette syndrome	0.000368	0.0238	CrCbGaD
Trazodone—Ziprasidone—HTR2A—Gilles de la Tourette syndrome	0.000364	0.0235	CrCbGaD
Trazodone—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000356	0.00339	CbGpPWpGaD
Trazodone—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000349	0.0226	CrCbGaD
Trazodone—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000347	0.0105	CbGeAlD
Trazodone—Loxapine—DRD3—Gilles de la Tourette syndrome	0.00034	0.022	CrCbGaD
Trazodone—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000334	0.0101	CbGeAlD
Trazodone—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000332	0.0215	CrCbGaD
Trazodone—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000331	0.0214	CrCbGaD
Trazodone—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000328	0.0212	CrCbGaD
Trazodone—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000322	0.00307	CbGpPWpGaD
Trazodone—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000317	0.0205	CrCbGaD
Trazodone—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000313	0.00298	CbGpPWpGaD
Trazodone—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000308	0.0199	CrCbGaD
Trazodone—Nefazodone—HTR2A—Gilles de la Tourette syndrome	0.000306	0.0198	CrCbGaD
Trazodone—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000297	0.0192	CrCbGaD
Trazodone—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000292	0.00278	CbGpPWpGaD
Trazodone—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000286	0.0185	CrCbGaD
Trazodone—Aripiprazole—HTR2A—Gilles de la Tourette syndrome	0.000284	0.0184	CrCbGaD
Trazodone—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000282	0.00268	CbGpPWpGaD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000276	0.00263	CbGpPWpGaD
Trazodone—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000274	0.00261	CbGpPWpGaD
Trazodone—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000269	0.0174	CrCbGaD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000268	0.00255	CbGpPWpGaD
Trazodone—ABCB1—brain—Gilles de la Tourette syndrome	0.000265	0.00805	CbGeAlD
Trazodone—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000264	0.00252	CbGpPWpGaD
Trazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000262	0.00249	CbGpPWpGaD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00026	0.00248	CbGpPWpGaD
Trazodone—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000255	0.00243	CbGpPWpGaD
Trazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000254	0.00242	CbGpPWpGaD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000253	0.00241	CbGpPWpGaD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00025	0.00238	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000248	0.00236	CbGpPWpGaD
Trazodone—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000237	0.0153	CrCbGaD
Trazodone—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000237	0.00225	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000236	0.00225	CbGpPWpGaD
Trazodone—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000236	0.0152	CrCbGaD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000235	0.00224	CbGpPWpGaD
Trazodone—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000234	0.0152	CrCbGaD
Trazodone—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.00023	0.0149	CrCbGaD
Trazodone—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000229	0.0148	CrCbGaD
Trazodone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000226	0.00215	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000225	0.00215	CbGpPWpGaD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000224	0.00213	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000223	0.00212	CbGpPWpGaD
Trazodone—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000221	0.00211	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000221	0.00211	CbGpPWpGaD
Trazodone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000219	0.00209	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000219	0.00208	CbGpPWpGaD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000218	0.00207	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000216	0.00206	CbGpPWpGaD
Trazodone—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000215	0.00205	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000215	0.00205	CbGpPWpGaD
Trazodone—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000213	0.00203	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00021	0.002	CbGpPWpGaD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000206	0.00196	CbGpPWpGaD
Trazodone—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000204	0.00195	CbGpPWpGaD
Trazodone—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000204	0.00195	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000204	0.00195	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000204	0.00194	CbGpPWpGaD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000203	0.00193	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000202	0.00192	CbGpPWpGaD
Trazodone—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0002	0.00191	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0002	0.00191	CbGpPWpGaD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0002	0.0019	CbGpPWpGaD
Trazodone—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000198	0.0128	CrCbGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000194	0.00184	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000193	0.00184	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000191	0.00182	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00019	0.00181	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00019	0.0018	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000188	0.00179	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000188	0.00179	CbGpPWpGaD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000186	0.00177	CbGpPWpGaD
Trazodone—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000185	0.00176	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000184	0.00175	CbGpPWpGaD
Trazodone—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000183	0.0119	CrCbGaD
Trazodone—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.000182	0.0118	CrCbGaD
Trazodone—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000181	0.00173	CbGpPWpGaD
Trazodone—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000181	0.0117	CrCbGaD
Trazodone—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.000178	0.0115	CrCbGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000176	0.00168	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000175	0.00167	CbGpPWpGaD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000175	0.00167	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000175	0.00166	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000171	0.00163	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000171	0.00163	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000171	0.00162	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00017	0.00162	CbGpPWpGaD
Trazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000166	0.00158	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000166	0.00158	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000165	0.00157	CbGpPWpGaD
Trazodone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000165	0.00157	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000165	0.00157	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.000163	0.00155	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000162	0.00154	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000159	0.00152	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000154	0.00147	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000154	0.00146	CbGpPWpGaD
Trazodone—Clozapine—HTR2A—Gilles de la Tourette syndrome	0.000153	0.00989	CrCbGaD
Trazodone—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000147	0.0014	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000147	0.0014	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000144	0.00137	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000143	0.00136	CbGpPWpGaD
Trazodone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000143	0.00136	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000143	0.00136	CbGpPWpGaD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000142	0.00135	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000141	0.00134	CbGpPWpGaD
Trazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00014	0.00133	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00014	0.00133	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000134	0.00128	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000133	0.00127	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000133	0.00127	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000133	0.00127	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000131	0.00124	CbGpPWpGaD
Trazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00013	0.00124	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00013	0.00124	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000129	0.00122	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00117	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000121	0.00115	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00012	0.00114	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000119	0.00113	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.000118	0.00112	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000115	0.0011	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000112	0.00106	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000108	0.00103	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000108	0.00103	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000108	0.00102	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000108	0.00102	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000105	0.000998	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.77e-05	0.00093	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.64e-05	0.000918	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.59e-05	0.000914	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.36e-05	0.000891	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.32e-05	0.000887	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.31e-05	0.000887	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.14e-05	0.000871	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	8.89e-05	0.000847	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.76e-05	0.000834	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.72e-05	0.00083	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.71e-05	0.00083	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.68e-05	0.000826	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.5e-05	0.00081	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.49e-05	0.000809	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.46e-05	0.000805	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	8.38e-05	0.000798	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.33e-05	0.000793	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.31e-05	0.000792	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.16e-05	0.000777	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.09e-05	0.00077	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.07e-05	0.000768	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.92e-05	0.000754	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.92e-05	0.000754	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.88e-05	0.00075	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.58e-05	0.000722	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.56e-05	0.00072	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.55e-05	0.000719	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.53e-05	0.000717	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.53e-05	0.000717	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.52e-05	0.000716	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.41e-05	0.000705	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.38e-05	0.000702	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.36e-05	0.000701	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.34e-05	0.000699	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.33e-05	0.000698	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.19e-05	0.000685	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.88e-05	0.000655	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.85e-05	0.000653	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.84e-05	0.000651	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.84e-05	0.000651	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.83e-05	0.00065	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.7e-05	0.000638	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.68e-05	0.000636	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.61e-05	0.000629	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.38e-05	0.000607	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.22e-05	0.000593	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.19e-05	0.00059	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.11e-05	0.000582	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.08e-05	0.000579	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.77e-05	0.000549	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.55e-05	0.000528	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.52e-05	0.000525	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	5.48e-05	0.000522	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.27e-05	0.000501	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.17e-05	0.000493	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.17e-05	0.000492	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.00049	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.02e-05	0.000478	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5e-05	0.000476	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.8e-05	0.000457	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.78e-05	0.000455	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.69e-05	0.000447	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.68e-05	0.000445	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.65e-05	0.000443	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.47e-05	0.000426	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.46e-05	0.000425	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.38e-05	0.000417	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.36e-05	0.000415	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.34e-05	0.000413	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.33e-05	0.000412	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.25e-05	0.000405	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.07e-05	0.000387	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.04e-05	0.000385	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.04e-05	0.000385	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.03e-05	0.000384	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.96e-05	0.000377	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.000376	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.00035	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.28e-05	0.000312	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.26e-05	0.00031	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.82e-05	0.000269	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.77e-05	0.000264	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000245	CbGpPWpGaD
